🇺🇸 FDA
Pipeline program

TARGET protocol EN 1.5 kcal/mL

ANZIC-RC/MC001

Phase 3 other completed

Quick answer

TARGET protocol EN 1.5 kcal/mL for Critical Illness is a Phase 3 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Zealand Pharma A/S
Indication
Critical Illness
Phase
Phase 3
Modality
other
Status
completed

Clinical trials